Wits RHI in the News

20 July 2017

Drug resistance a major setback to HIV fight

More and more countries are reaching the “threshold” of resistance to the most commonly-used HIV drugs which could “undermine global progress in treating and preventing HIV”, according to the World Health Organisation (WHO).

Read More

20 July 2017

New ARV drug a game-changer for HIV​ patients

The much-anticipated antiretroviral (ARV) dolutegravir will be introduced as the first-line treatment for the HIV infected in South Africa as early as April, Health Department deputy director-general Dr Yogan Pillay said at the 9th International Aids Society (IAS) conference on HIV Science in Paris this week.

Read More

20 April 2017

Contraception the answer to epidemic of teen pregnancies

Alarming research has found that two-thirds of women of child-bearing age have had an unplanned pregnancy in the last five years.

Read More

20 February 2017

FACT-CHECKED: 2 claims about slavery & ‘child prostitutes’ in SA

The manager of a South African anti-human trafficking helpline made two claims about the number of slaves and 'child prostitutes' in South Africa. Africa Check investigated these startling claims.

Read More

20 February 2017

HIV home-testing kits at your corner chemist

Pharmacies are no longer prohibited from selling HIV self-testing kits.

Read More

20 February 2017

New ARV Combo Study Launched

A study to evaluate a new antiretroviral drug combination for the treatment of HIV was launched yesterday by the Wits Reproductive Health and HIV Institute (RHI) together with its partners.

Read More

29 August 2016

Drug to prevent HIV gets the official nod

A pill that protects against HIV has been approved for use in South Africa. Truvada, which contains two antiretrovirals, offers more than 90% protection against HIV if taken every day. Professor Francois Venter, Deputy Director of the Wits Reproductive Health and HIV Institute, welcomes the Medicines Control Council’s approval of the drug, saying: “There are no magic bullets in HIV prevention but we desperately need new and better options.

Read More

29 August 2016

What’s needed in the final push to eliminate new cases of HIV in children?

The prevention of HIV from mothers to children has been the most successful HIV prevention programme in South Africa and across the globe. However Dr Lee Fairlie, Technical Head from Wits RHI, believes that certain areas need attention to reduce the burden of paediatric HIV.

Read More

29 August 2016

What drove women to lie in an HIV clinical trial in southern Africa?

Two years ago women were found to have lied in a clinical trial in South Africa for a new HIV drug. The VOICE trial was unsuccessful due to low adherence. When the trial was completed it was revealed many women involved had not been honest about their adherence to the drug regime they had signed up to take. Jonathan Stadler, Technical Head, from Wits RHI explains his findings in this article.

Read More

29 August 2016

2 Wits PhD students breaking new ground in HIV/Aids research

Wits RHI would like to congratulate Shobna Sawry our Programme Manager in Paediatric Research for receiving the LÓreal Unesco Regional Sub-Saharan Fellowship. This funding from global cosmetics giant L’Oreal will be used towards furthering her HIV/Aids research in paediatrics.

702’s Azania Mosaka spoke to her about her respective research subject and her vision for the role of science in eradicating the spread of HIV.

Read More

Subscribe to our Newsletter